• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

范可尼贫血的骨髓移植

Bone marrow transplantation in Fanconi anaemia.

作者信息

Gluckman E, Devergie A, Schaison G, Bussel A, Berger R, Sohier J, Bernard J

出版信息

Br J Haematol. 1980 Aug;45(4):557-64. doi: 10.1111/j.1365-2141.1980.tb07178.x.

DOI:10.1111/j.1365-2141.1980.tb07178.x
PMID:7000153
Abstract

Five patients with Fanconi anaemia have been treated by bone marrow transplantation from HLA identical donors. Only one patient survived for more than 3 years. She is now perfectly healthy with complete haematological reconstitution with chimaerism and disparition of chromosomal abnormalities. In contrast, four patients died of acute severe GVHD soon after grafting. In addition, all had signs of severe cyclophosphamide toxicity. This evolution could be explained by a special sensitivity of FA cells to alkylating agents and may indicate the need to modify the conditioning regimen in FA patients.

摘要

五名范可尼贫血患者接受了来自 HLA 相同供体的骨髓移植治疗。只有一名患者存活超过 3 年。她现在完全健康,血液学完全重建,有嵌合体形成且染色体异常消失。相比之下,四名患者在移植后不久死于急性严重移植物抗宿主病(GVHD)。此外,所有患者都有严重的环磷酰胺毒性迹象。这种病情发展可以用范可尼贫血(FA)细胞对烷化剂的特殊敏感性来解释,这可能表明需要调整 FA 患者的预处理方案。

相似文献

1
Bone marrow transplantation in Fanconi anaemia.范可尼贫血的骨髓移植
Br J Haematol. 1980 Aug;45(4):557-64. doi: 10.1111/j.1365-2141.1980.tb07178.x.
2
Bone marrow transplantation for Fanconi anemia. Adjustment of the dose of cyclophosphamide for preconditioning.范可尼贫血的骨髓移植。预处理中环磷酰胺剂量的调整。
Am J Pediatr Hematol Oncol. 1993 Nov;15(4):377-82.
3
[The human bone marrow transplant. II. The transplant in aplastic anemia].[人类骨髓移植。II. 再生障碍性贫血中的移植]
Recenti Prog Med. 1983 Feb;74(2):199-213.
4
Fanconi's anemia treated by allogeneic marrow transplantation.通过异基因骨髓移植治疗范科尼贫血。
Blood. 1983 May;61(5):954-9.
5
[Bone marrow transplantation in Fanconi's anaemia (author's transl)].
Sangre (Barc). 1981;26(3):380-2.
6
Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outcome.范可尼贫血或获得性再生障碍性贫血患者接受来自 HLA 相同同胞供者的骨髓移植后的急性移植物抗宿主病:危险因素及对预后的影响
Blood. 2004 Jan 1;103(1):73-7. doi: 10.1182/blood-2003-06-2146. Epub 2003 Aug 28.
7
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.再生障碍性贫血和范可尼贫血骨髓移植后的恶性肿瘤:西雅图和巴黎对700例患者结果的联合分析
Blood. 1996 Jan 1;87(1):386-92.
8
[Treatment of Fanconi anemia by bone marrow transplantation].[通过骨髓移植治疗范可尼贫血]
Monatsschr Kinderheilkd. 1987 May;135(5):253-8.
9
Unrelated donor bone marrow transplantation in Fanconi anaemia: the Leiden experience.
Bone Marrow Transplant. 1998 Mar;21(5):447-53. doi: 10.1038/sj.bmt.1701111.
10
Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation.范可尼贫血的放射敏感性:在骨髓移植预处理方案中的应用
Br J Haematol. 1983 Jul;54(3):431-40. doi: 10.1111/j.1365-2141.1983.tb02117.x.

引用本文的文献

1
Hematopoietic Stem Cell Transplant in Adult Patients with Fanconi Anemia: A Review.成人范可尼贫血患者的造血干细胞移植:综述
Diseases. 2025 Jun 25;13(7):195. doi: 10.3390/diseases13070195.
2
Hepatocyte senescence and persistent liver injury in Fanconi anemia.范可尼贫血中的肝细胞衰老与持续性肝损伤。
Haematologica. 2025 Aug 1;110(8):1870-1874. doi: 10.3324/haematol.2024.287096. Epub 2025 Mar 6.
3
Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia.槲皮素对患有范可尼贫血的儿童和年轻人的1期研究,槲皮素是一种天然抗氧化剂。
Blood Adv. 2025 Apr 22;9(8):1927-1939. doi: 10.1182/bloodadvances.2024015053.
4
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies.儿童范可尼贫血中髓母细胞瘤:与 FA-D1/FA-N、SHH 型相关,且独立于治疗策略,生存预后较差。
Neuro Oncol. 2024 Nov 4;26(11):2125-2139. doi: 10.1093/neuonc/noae111.
5
T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML.T 细胞耗竭的同种异基因造血干细胞移植治疗范可尼贫血和 MDS/AML。
Bone Marrow Transplant. 2024 Jan;59(1):23-33. doi: 10.1038/s41409-023-02113-1. Epub 2023 Sep 29.
6
Venetoclax and Azacitidine in the Treatment of -Mutated Donor Cell-Derived Leukemia in a Patient With Fanconi Anemia: Case Report and Literature Review.维奈托克与阿扎胞苷治疗范可尼贫血患者中 - 突变供体细胞衍生白血病:病例报告及文献综述
JCO Precis Oncol. 2023 Jun;7:e2200693. doi: 10.1200/PO.22.00693.
7
An update on Fanconi anemia: Clinical, cytogenetic and molecular approaches (Review).范可尼贫血的最新进展:临床、细胞遗传学和分子学方法(综述)
Biomed Rep. 2021 Sep;15(3):74. doi: 10.3892/br.2021.1450. Epub 2021 Jul 15.
8
Canonical and Noncanonical Roles of Fanconi Anemia Proteins: Implications in Cancer Predisposition.范可尼贫血蛋白的典型和非典型作用:对癌症易感性的影响
Cancers (Basel). 2020 Sep 20;12(9):2684. doi: 10.3390/cancers12092684.
9
Effective Multi-lineage Engraftment in a Mouse Model of Fanconi Anemia Using Non-genotoxic Antibody-Based Conditioning.在范可尼贫血小鼠模型中使用基于非基因毒性抗体的预处理实现有效的多谱系植入。
Mol Ther Methods Clin Dev. 2020 Feb 8;17:455-464. doi: 10.1016/j.omtm.2020.02.001. eCollection 2020 Jun 12.
10
Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients.白消安在儿童范可尼贫血患者中的群体药代动力学建模及身体成分的影响
Br J Clin Pharmacol. 2020 May;86(5):933-943. doi: 10.1111/bcp.14202. Epub 2020 Jan 23.